A method for the determination of the level of Streptococcus mutans in saliva samples was developed. The method was a modification of a previously described technique based on the ability of this microorganism to adhere to the walls of test tubes when growing in a selective sucrose-containing medium. An aliquot of the saliva samples was inoculated into a sucrose-sulphasomidine (Elkosin®)-broth (SEB). The test tube was tilted at a 40° angle and incubated aerobically at 37 °C for 24 h. The broth was removed, the tube rinsed carefully with water after which the amount of the adherent deposits was scored into one of four classes (≤ 103,104, 105 and ≥ 106 S. mutans/ml saliva). The number of S. mutans in 380 paraffin-stimulated whole saliva samples was determined after culturing on Mitis Salivarius Bacitracin agar plates and in SEB. A high correlation was found between the two methods. The level of S. mutans was diagnosed the same in 86% when 137 of the 380 saliva samples were cultured in both freshly prepared and 6-month-old medium. The SEB method is simple and inexpensive and may be used, e.g. in epidemiological studies and in routine practise, for the determination of the level of S. mutans in saliva samples.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.